PAB 16.7% 0.7¢ patrys limited

2024 An Eventful Year, page-3

  1. 3,149 Posts.
    lightbulb Created with Sketch. 249
    "Maybe even this???"
    I couldn't open that link gassed but I think I got an idea of what it's about from the link. There does seem to be a lot of activity by the big pharmas in the ADC area.
    Not to be outdone by its Big Pharma peers, Johnson & Johnson has fattened up its antibody-drug conjugate (ADC) pipeline via the acquisition of Ambrx Biopharma for $2 billion.
    Link to the article below. I would be happy with a $2b offer for PAB. It would equate to a share price of around Ninety cents US -

    J&J beefs up ADC pipeline by acquiring Ambrx for $2B (fiercebiotech.com)

 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.001(16.7%)
Mkt cap ! $12.34M
Open High Low Value Volume
0.7¢ 0.7¢ 0.6¢ $903 131.6K

Buyers (Bids)

No. Vol. Price($)
6 2116616 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 888130 2
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.